About UsNewsShop
Fighting hereditary breast and ovarian cancer
Information & Research
| More

PARP Inhibitor TNBC Clinical Trials


PARP Inhibitor Clinical Trials for Triple Negative Breast Cancer

The below studies are PARP inhibitor studies that are currently enrolling patients with triple-negative breast cancer. For more details on an individual study, please contact the study coordinator or visit clinicaltrials.gov.


Page updated 08/31/11

Disclaimer: Health links are made available for educational purposes only. This information should not be interpreted as medical advice. All health information should be discussed with your health care provider. Please read our full disclaimer for more information.

Privacy Policy | Sitemap | Contact Us


This site has been made possible by a generous grant from Morphotek.

Web design by Rareheron Web Design

copyright © FORCE: Facing Our Risk of Cancer Empowered, Inc.  •  info@facingourrisk.org